{"organizations": [], "uuid": "45074a1c76e9b83403d2d1bd0e4be6e7e759c369", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180508.html", "section_title": "Archive News &amp; Video for Tuesday, 08 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/valeant-pharm-in-results/valeant-pharma-reports-quarterly-loss-to-change-name-to-bausch-health-idUSL3N1SF4FS", "country": "US", "domain_rank": 408, "title": "Valeant Pharma reports quarterly loss, to change name to Bausch Health", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.017, "site_type": "news", "published": "2018-05-08T19:10:00.000+03:00", "replies_count": 0, "uuid": "45074a1c76e9b83403d2d1bd0e4be6e7e759c369"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/valeant-pharm-in-results/valeant-pharma-reports-quarterly-loss-to-change-name-to-bausch-health-idUSL3N1SF4FS", "ord_in_thread": 0, "title": "Valeant Pharma reports quarterly loss, to change name to Bausch Health", "locations": [], "entities": {"persons": [{"name": "manas mishra", "sentiment": "none"}, {"name": "arun koyyur", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "bausch health", "sentiment": "negative"}, {"name": "valeant pharma", "sentiment": "negative"}, {"name": "valeant pharmaceuticals international inc", "sentiment": "negative"}, {"name": "bausch health companies inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 8 (Reuters) - Valeant Pharmaceuticals International Inc reported first-quarter loss compared with a year-ago profit and said on Tuesday it would change its name to Bausch Health Companies Inc.\nNet loss attributable to the company was at $2.69 billion, or $7.68 per share, in the quarter ended March 31, compared with a profit of $628 million, or $1.79 per share, a year earlier.\nTotal revenues fell 5.4 percent to $1.96 billion.\nReporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-08T19:10:00.000+03:00", "crawled": "2018-05-09T12:19:11.002+03:00", "highlightTitle": ""}